Boston Scientific Announces Results for Third Quarter 2022

Go back to Boston Scientific Announces Results for Third Quarter 2022

Boston Scientific (BSX) Misses Q3 EPS by 1c

October 26, 2022 6:31 AM EDT

Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.43, $0.01 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $3.17 billion versus the consensus estimate of $3.15 billion.

GUIDANCE:

Boston Scientific sees Q4 2022 EPS of $0.45-$0.48, versus the consensus of... More